Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginexin for orthostatic intolerance
KCT0010336Phase 4Completed
- Sponsor
- SK Chemicals
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Vasoclean in orthostatic intolerance, orthostatic hypotension (OH), postural orthostatic tachycardia syndrome (POTS), sponsored by SK Chemicals. Started Apr 2025; status: completed.
02
Drugs
Vasoclean
03
Conditions
orthostatic intoleranceorthostatic hypotension (OH)postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on KCT0010336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010336.